✉news BusinessStartups first seen 1 d ago, last 1 d ago, peak #20
UCB Partners With AI Startup Cradle on Antibody Drug Design
Original: UCB Taps AI Startup Cradle to Help Design Antibody Drugs
Belgian biotech UCB is working with AI drug-design startup Cradle to help develop antibody-based medicines. The tie-up puts generative AI tools at the heart of UCB's early-stage drug discovery, as large pharma companies increasingly turn to artificial intelligence startups to speed up and cut the cost of designing new biologics.
Why now: Pharma's embrace of AI for drug discovery is a fast-growing story and this is a fresh high-profile example.
Rank over time, top of the chart is #1. 9 snapshots from 1 d ago to 1 d ago.
Evidence
- UCB Taps AI Startup Cradle to Help Design Antibody Drugs · Bloomberg.com
API: https://socialmediatrends-api.osmike.com/v1/trends/4771719